Search results
Author(s):
Ahmed Gonnah
,
Nadhrah Darke
,
Liam Mullen
,
et al
Added:
7 months ago
OPTION–STEMI: Immediate Complete Revascularisation Fails to Show Non-Inferiority to Staged Approach
Added:
2 months ago
Source:
Transcatheter Academy
News
Author(s):
Thomas Engstrøm
Added:
5 months ago
EuroPCR 25 - 10-year outcomes from DANAMI-3-PRIMULTI show FFR-guided complete revascularisation in ST-elevation myocardial infarction (STEMI) reduces the risk of future events. We are joined by Dr Thomas Engstrøm (University of Copenhagen, Copenhagen, Denmark) to discuss 10-year outcomes from the multicenter, randomized DANAMI-3-PRIMULTI trial investigating FFR-guided complete…
View more
Author(s):
Tara Jones
Added:
1 month ago
Learn about revascularisation strategies in cardiogenic shock after acute MI, including culprit-only vs multivessel PCI, from Dr Tara Jones (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick…
View more
Author(s):
Gianluca Campo
Added:
1 year ago
ESC Congress 2024 — Complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality.We are joined onsite by Dr Gianluca Campo (University of Ferrara, Ferrara, IT) to discuss the findings from EARTH-STEMI. Previous RCTs have supported the benefit of complete revascularisation in the overall population, however, this has not been confirmed in…
View more
13th Complete Revasc: Live Case Course in Modern PCI
Video Series
Author(s):
Jia Min Chua
,
Paul Jau Lueng Ong
,
Randal Jun Bang Low
Added:
3 months ago
Added:
1 month ago
Source:
Transcatheter Academy
The long-term durability of complete revascularization in older patients with myocardial infarction (MI) and multivessel disease has been a subject of recent debate. New 3-year follow-up data from the Functional Assessment in Elderly MI Patients With Multivessel Disease (FIRE) trial show that the clinical benefits of a physiology-guided complete revascularization strategy are sustained over time…
View more
TCT 23: IFR SWEDEHEART
Author(s):
Matthias Götberg
Added:
2 years ago
Video